Graham Capital Management’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,577,900
Closed -$2.32M 1457
2024
Q4
$2.32M Sell
1,577,900
-573,800
-27% -$877K 0.03% 259
2024
Q3
$3.21M Sell
2,151,700
-48,700
-2% -$72.3K 0.06% 183
2024
Q2
$2.75M Buy
+2,200,400
New +$2.85M 0.06% 182
2015
Q1
Sell
-595,000
Closed -$5.94M 145
2014
Q4
$5.94M Buy
595,000
+58,200
+11% +$498K 0.25% 64
2014
Q3
$4.57M Buy
536,800
+336,800
+168% +$2.96M 0.2% 84
2014
Q2
$1.77M Buy
+200,000
New +$1.75M 0.05% 114

Other funds holding OPK

Graham Capital Management's OPK Position: Q1 2026 in Review

Graham Capital Management reduced its Opko Health (OPK) stake by 56% in Q1 2026, selling an estimated $82.2K and leaving 52,859 shares worth $60.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

Graham Capital Management first reported a position in OPK in Q4 2021 and has held it in 14 quarters since. The position peaked at $3.01M in Q1 2025. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • Graham Capital Management held 52,859 shares of Opko Health worth $60.3K as of Q1 2026.
  • Graham Capital Management sold 66,795 Opko Health shares in Q1 2026, an estimated $82.2K.
  • Opko Health made up ﹤0.01% of Graham Capital Management's portfolio in Q1 2026, its #1080 holding.
  • Graham Capital Management first reported a position in Opko Health in Q4 2021 and has held it in 14 quarters since.
  • Graham Capital Management's Opko Health position peaked at $3.01M in Q1 2025.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.